Cargando…
TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice
Neutralization of tumor necrosis factor (TNF) represents a widely used therapeutic strategy for autoimmune diseases including inflammatory bowel disease (IBD). However, the fact that many patients with IBD are non-responsive to anti-TNF therapies suggests the need for a better understanding of TNF s...
Autores principales: | Liu, Cambrian Y., Tam, Sharon S., Huang, Ying, Dubé, Philip E., Alhosh, Rabea, Girish, Nandini, Punit, Shivesh, Nataneli, Shirin, Li, Fan, Bender, Jeffrey M., Washington, M. Kay, Polk, D. Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682618/ https://www.ncbi.nlm.nih.gov/pubmed/33086075 http://dx.doi.org/10.1016/j.celrep.2020.108275 |
Ejemplares similares
-
Colitis-induced upregulation of tumor necrosis factor receptor-2 (TNFR2) terminates epithelial regenerative signaling to restore homeostasis
por: Sharifkhodaei, Zohreh, et al.
Publicado: (2023) -
Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice
por: Dubé, Philip E., et al.
Publicado: (2018) -
ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival
por: ZHANG, YONGQIN, et al.
Publicado: (2011) -
Targeted Colonic Claudin-2 Expression Renders Resistance to Epithelial Injury, Induces Immune Suppression and Protects from Colitis
por: Ahmad, Rizwan, et al.
Publicado: (2014) -
NRG4-ErbB4 signaling represses proinflammatory macrophage activity
por: Schumacher, Michael A., et al.
Publicado: (2021)